Cargando…
Patient-reported outcomes in breast cancer FDA drug labels and review documents
BACKGROUND: Patient-reported outcomes (PROs) can provide valuable information about drug benefit-risk tradeoffs from the patient perspective and are particularly important to patients with breast cancer due to its symptoms and adverse events from breast cancer treatments. The United States Food and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060367/ https://www.ncbi.nlm.nih.gov/pubmed/33881661 http://dx.doi.org/10.1186/s41687-021-00308-y |